AORT: Artivion Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Artivion Inc (AORT).

OverviewDividends

$1.20B Market Cap.

As of 05/06/2025 5:00 PM ET (MRY) • Disclaimer

AORT Market Cap. (MRY)


AORT Shares Outstanding (MRY)


AORT Assets (MRY)


Total Assets

$789.10M

Total Liabilities

$512.90M

Total Investments

$0

AORT Income (MRY)


Revenue

$388.54M

Net Income

-$13.36M

Operating Expense

$209.91M

AORT Cash Flow (MRY)


CF Operations

$22.24M

CF Investing

-$28.19M

CF Financing

$2.20M

AORT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$789,101,000 (-0.42%)

$792,397,000 (3.88%)

$762,798,000 (-3.81%)

$793,052,000 (0.46%)

Assets Current

$290,080,000 (3.35%)

$280,668,000 (13.48%)

$247,334,000 (-0.15%)

$247,697,000 (5.59%)

Assets Non-Current

$499,021,000 (-2.48%)

$511,729,000 (-0.72%)

$515,464,000 (-5.48%)

$545,355,000 (-1.71%)

Goodwill & Intangible Assets

$397,341,000 (-5.30%)

$419,568,000 (-1.57%)

$426,278,000 (-5.59%)

$451,496,000 (-7.31%)

Shareholders Equity

$276,200,000 (-1.98%)

$281,780,000 (-0.90%)

$284,329,000 (-5.45%)

$300,728,000 (-8.51%)

Property Plant & Equipment Net

$76,129,000 (-7.36%)

$82,180,000 (2.05%)

$80,533,000 (-3.25%)

$83,235,000 (61.16%)

Cash & Equivalents

$53,463,000 (-9.29%)

$58,940,000 (49.78%)

$39,351,000 (-28.47%)

$55,010,000 (-10.42%)

Accumulated Other Comprehensive Income

-$24,927,000 (-107.55%)

-$12,010,000 (44.42%)

-$21,609,000 (-118.56%)

-$9,887,000 (-246.63%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$79,766,000 (-2.70%)

$81,976,000 (10.07%)

$74,478,000 (-3.24%)

$76,971,000 (5.38%)

Trade & Non-Trade Receivables

$85,893,000 (15.86%)

$74,138,000 (6.54%)

$69,584,000 (19.76%)

$58,105,000 (19.18%)

Trade & Non-Trade Payables

$17,971,000 (34.94%)

$13,318,000 (10.95%)

$12,004,000 (15.48%)

$10,395,000 (8.02%)

Accumulated Retained Earnings (Deficit)

-$61,266,000 (-27.89%)

-$47,907,000 (-178.25%)

-$17,217,000 (-971.75%)

$1,975,000 (-90.14%)

Tax Assets

$1,068,000 (-1.75%)

$1,087,000 (-17.28%)

$1,314,000 (-44.25%)

$2,357,000 (63.00%)

Tax Liabilities

$23,117,000 (-10.02%)

$25,691,000 (-5.32%)

$27,134,000 (-16.34%)

$32,433,000 (-13.56%)

Total Debt

$362,258,000 (1.09%)

$358,341,000 (0.42%)

$356,829,000 (-1.44%)

$362,043,000 (14.07%)

Debt Current

$5,285,000 (-2.63%)

$5,428,000 (-0.02%)

$5,429,000 (2.30%)

$5,307,000 (-29.91%)

Debt Non-Current

$356,973,000 (1.15%)

$352,913,000 (0.43%)

$351,400,000 (-1.50%)

$356,736,000 (15.15%)

Total Liabilities

$512,901,000 (0.45%)

$510,617,000 (6.72%)

$478,469,000 (-2.81%)

$492,324,000 (6.87%)

Liabilities Current

$66,823,000 (15.49%)

$57,862,000 (16.48%)

$49,675,000 (10.50%)

$44,953,000 (-25.66%)

Liabilities Non-Current

$446,078,000 (-1.47%)

$452,755,000 (5.59%)

$428,794,000 (-4.15%)

$447,371,000 (11.78%)

AORT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$388,537,000 (9.75%)

$354,004,000 (12.82%)

$313,789,000 (5.00%)

$298,836,000 (18.01%)

Cost of Revenue

$139,756,000 (11.96%)

$124,828,000 (12.19%)

$111,266,000 (9.81%)

$101,322,000 (18.58%)

Selling General & Administrative Expense

$181,455,000 (-13.17%)

$208,977,000 (32.73%)

$157,443,000 (-7.26%)

$169,774,000 (20.29%)

Research & Development Expense

$28,452,000 (-0.89%)

$28,707,000 (-26.16%)

$38,879,000 (9.38%)

$35,546,000 (46.84%)

Operating Expenses

$209,907,000 (-11.69%)

$237,684,000 (21.07%)

$196,322,000 (-4.38%)

$205,320,000 (24.18%)

Interest Expense

$34,277,000 (35.49%)

$25,299,000 (38.82%)

$18,224,000 (7.92%)

$16,887,000 (1.13%)

Income Tax Expense

$5,845,000 (-35.80%)

$9,104,000 (116.35%)

$4,208,000 (60014.29%)

$7,000 (101.42%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$13,359,000 (56.47%)

-$30,690,000 (-59.91%)

-$19,192,000 (-29.38%)

-$14,834,000 (11.08%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$13,359,000 (56.47%)

-$30,690,000 (-59.91%)

-$19,192,000 (-29.38%)

-$14,834,000 (11.08%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$13,359,000 (56.47%)

-$30,690,000 (-59.91%)

-$19,192,000 (-29.38%)

-$14,834,000 (11.08%)

Weighted Average Shares

$41,676,000 (2.29%)

$40,743,000 (1.78%)

$40,032,000 (2.69%)

$38,983,000 (2.96%)

Weighted Average Shares Diluted

$41,676,000 (2.29%)

$40,743,000 (1.78%)

$40,032,000 (2.69%)

$38,983,000 (2.96%)

Earning Before Interest & Taxes (EBIT)

$26,763,000 (620.79%)

$3,713,000 (14.60%)

$3,240,000 (57.28%)

$2,060,000 (532.77%)

Gross Profit

$248,781,000 (8.55%)

$229,176,000 (13.16%)

$202,523,000 (2.54%)

$197,514,000 (17.72%)

Operating Income

$38,874,000 (556.91%)

-$8,508,000 (-237.20%)

$6,201,000 (179.44%)

-$7,806,000 (-419.79%)

AORT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$28,188,000 (-5515.14%)

-$502,000 (95.31%)

-$10,715,000 (-289.31%)

$5,660,000 (107.74%)

Net Cash Flow from Financing

$2,203,000 (154.68%)

$865,000 (152.78%)

-$1,639,000 (86.59%)

-$12,223,000 (-113.06%)

Net Cash Flow from Operations

$22,236,000 (18.12%)

$18,825,000 (465.32%)

-$5,153,000 (-99.34%)

-$2,585,000 (-120.90%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$5,477,000 (-127.96%)

$19,589,000 (225.10%)

-$15,659,000 (-125.37%)

-$6,948,000 (-125.12%)

Net Cash Flow - Business Acquisitions and Disposals

-$17,000,000 (-240.00%)

-$5,000,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$14,250,000 (0%)

$0 (0%)

$19,000,000 (0%)

Capital Expenditure

-$11,188,000 (-14.73%)

-$9,752,000 (8.99%)

-$10,715,000 (18.15%)

-$13,091,000 (-78.64%)

Issuance (Repayment) of Debt Securities

-$2,902,000 (47.73%)

-$5,552,000 (-101.67%)

-$2,753,000 (48.10%)

-$5,304,000 (-105.83%)

Issuance (Purchase) of Equity Shares

$5,728,000 (68.67%)

$3,396,000 (115.89%)

$1,573,000 (-14.60%)

$1,842,000 (321.51%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$1,728,000 (-530.92%)

$401,000 (-78.30%)

$1,848,000 (-16.00%)

$2,200,000 (142.43%)

Share Based Compensation

$14,242,000 (-1.25%)

$14,422,000 (16.83%)

$12,344,000 (15.25%)

$10,711,000 (54.96%)

Depreciation Amortization & Accretion

$29,120,000 (5.44%)

$27,617,000 (1.88%)

$27,108,000 (-13.94%)

$31,498,000 (13.07%)

AORT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

64.00% (-1.08%)

64.70% (0.31%)

64.50% (-2.42%)

66.10% (-0.30%)

Profit Margin

-3.40% (60.92%)

-8.70% (-42.62%)

-6.10% (-22.00%)

-5.00% (24.24%)

EBITDA Margin

14.40% (61.80%)

8.90% (-8.25%)

9.70% (-13.39%)

11.20% (3.70%)

Return on Average Equity (ROAE)

-4.60% (58.18%)

-11.00% (-59.42%)

-6.90% (-40.82%)

-4.90% (9.26%)

Return on Average Assets (ROAA)

-1.70% (57.50%)

-4.00% (-60.00%)

-2.50% (-38.89%)

-1.80% (21.74%)

Return on Sales (ROS)

6.90% (590.00%)

1.00% (0.00%)

1.00% (42.86%)

0.70% (450.00%)

Return on Invested Capital (ROIC)

4.40% (633.33%)

0.60% (20.00%)

0.50% (25.00%)

0.40% (500.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-89.34 (-274.77%)

-23.84 (5.58%)

-25.25 (52.85%)

-53.55 (0.20%)

Price to Sales Ratio (P/S)

3.07 (49.03%)

2.06 (33.12%)

1.55 (-41.77%)

2.65 (-24.79%)

Price to Book Ratio (P/B)

4.34 (66.56%)

2.6 (51.54%)

1.72 (-35.40%)

2.66 (-4.66%)

Debt to Equity Ratio (D/E)

1.86 (2.48%)

1.81 (7.66%)

1.68 (2.81%)

1.64 (16.85%)

Earnings Per Share (EPS)

-0.32 (57.33%)

-0.75 (-56.25%)

-0.48 (-26.32%)

-0.38 (13.64%)

Sales Per Share (SPS)

9.32 (7.30%)

8.69 (10.86%)

7.84 (2.24%)

7.67 (14.62%)

Free Cash Flow Per Share (FCFPS)

0.27 (18.83%)

0.22 (156.31%)

-0.4 (1.49%)

-0.4 (-402.26%)

Book Value Per Share (BVPS)

6.63 (-4.18%)

6.92 (-2.63%)

7.1 (-7.92%)

7.71 (-11.15%)

Tangible Assets Book Value Per Share (TABVPS)

9.4 (2.72%)

9.15 (8.86%)

8.41 (-4.06%)

8.76 (9.74%)

Enterprise Value Over EBIT (EV/EBIT)

56 (-80.00%)

280 (12.45%)

249 (-53.11%)

531 (121.70%)

Enterprise Value Over EBITDA (EV/EBITDA)

26.94 (-18.69%)

33.13 (24.61%)

26.59 (-18.44%)

32.6 (-23.37%)

Asset Turnover

0.49 (7.68%)

0.46 (10.95%)

0.41 (10.48%)

0.37 (5.98%)

Current Ratio

4.34 (-10.51%)

4.85 (-2.57%)

4.98 (-9.64%)

5.51 (42.01%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$11,048,000 (21.77%)

$9,073,000 (157.18%)

-$15,868,000 (-1.22%)

-$15,676,000 (-410.97%)

Enterprise Value (EV)

$1,505,431,827 (45.04%)

$1,037,971,111 (28.64%)

$806,883,310 (-26.24%)

$1,093,992,953 (-6.08%)

Earnings Before Tax (EBT)

-$7,514,000 (65.19%)

-$21,586,000 (-44.06%)

-$14,984,000 (-1.06%)

-$14,827,000 (13.67%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$55,883,000 (78.37%)

$31,330,000 (3.24%)

$30,348,000 (-9.57%)

$33,558,000 (22.56%)

Invested Capital

$633,732,000 (3.15%)

$614,368,000 (1.66%)

$604,323,000 (0.11%)

$603,636,000 (21.27%)

Working Capital

$223,257,000 (0.20%)

$222,806,000 (12.72%)

$197,659,000 (-2.51%)

$202,744,000 (16.44%)

Tangible Asset Value

$391,760,000 (5.08%)

$372,829,000 (10.79%)

$336,520,000 (-1.47%)

$341,556,000 (12.99%)

Market Capitalization

$1,198,489,827 (63.29%)

$733,949,111 (50.16%)

$488,793,310 (-38.93%)

$800,356,953 (-12.76%)

Average Equity

$292,745,000 (4.91%)

$279,045,000 (-0.20%)

$279,609,500 (-7.68%)

$302,858,750 (-1.32%)

Average Assets

$791,447,750 (2.05%)

$775,529,500 (1.63%)

$763,062,250 (-5.12%)

$804,258,750 (11.47%)

Invested Capital Average

$612,963,750 (0.47%)

$610,088,750 (0.80%)

$605,272,750 (3.32%)

$585,808,000 (21.36%)

Shares

41,919,896 (2.12%)

41,048,608 (1.78%)

40,329,481 (2.54%)

39,329,580 (1.22%)